Prior studies suggest that TGF-β-mediated EMT induction may depend on Smad4 deficiency, as Smad4 inactivation impairs TGF-β-induced apoptosis and tumor-suppressive effects (Levy and Hill, 2005). The gene discussed is SMAD4; the disease is neoplasm.